Aclaris therapeutics announces divestiture of rhofade

Aclaris therapeutics announces divestiture of rhofade®.aclaris therapeutics inc - divestiture of rhofade is a key component of aclaris' recently announced strategic plan.aclaris therapeutics inc - epi health has agreed to pay aclaris total cash consideration of up to $55.0 million.aclaris therapeutics inc - concurrently with closing aclaris repaid in full its $30 million term loan with oxford finance llc..aclaris - expect current cash, equivalents, marketable securities, repayment of outstanding term loan, will be sufficient to fund operations into q3 2021.aclaris therapeutics inc - divested rhofad and related intellectual property assets to epi health.aclaris therapeutics - concurrently with closing of transaction, aclaris repaid in full its $30 million term loan with oxford finance llc.
ACRS Ratings Summary
ACRS Quant Ranking